The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Open accessAbstract
Non-alcoholic fatty liver disease is a serious and growing clinical problem. Despite lifestyle modification, i.e. diet and physical activity, being the recommended therapy, there are currently no systematic evaluations of its efficacy. This review applies a systematic approach to evaluating lifestyle modifications studied to date. Medline (Pubmed), Scopus, and the Cochrane Controlled Trials Register were searched for studies and study groups assessing the effect of diet, physical activity, and/or exercise modification in adult populations with non-alcoholic fatty liver disease. The outcome markers of interest were indicators of steatosis, histological evidence of inflammation and fibrosis, and glucose control/insulin sensitivity. We identified 23 studies for inclusion; seven had control groups, but only six were randomised. Eleven groups received diet-only interventions, two exercise-only, and 19 diet and physical activity/exercise. Studies consistently showed reductions in liver fat and/or liver aminotransferase concentration, with the strongest correlation being with weight reduction. Of the 5 studies reporting changes in histopathology, all showed a trend towards reduction in inflammation, in 2 this was statistically significant. Changes in fibrosis were less consistent with only one study showing a significant reduction. The majority of studies also reported improvements in glucose control/insulin sensitivity following intervention. However, study design, definition of disease, assessment methods, and interventions varied considerably across studies. Lifestyle modifications leading to weight reduction and/or increased physical activity consistently reduced liver fat and improved glucose control/insulin sensitivity. Limited data also suggest that lifestyle interventions may hold benefits for histopathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A meta-analysis of lifestyle interventions in people with MASLD identified weight loss of between 4% and14% with a corresponding reduction in liver fat of 4–10%.27”
From Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD (2025) · cites this paper as [27]
Citations
Cites
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationSzczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
MOFRAD, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,199
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 751
Exercise for type 2 diabetes mellitus
Thomas, D., Elliott, E. J., & Naughton, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002968.pub2 · Cited by 728
Fracanzani, A. L., Valenti, L. V. C., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 716
Flagged first, then by citations
4 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 523
Hao, X., Song, H., Su, X. Y., Li, J., Ye, Y., Wang, C., Xu, X. D., Pang, G., Liu, W., Li, Z., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2464223 · Cited by 18
Chan, W., Hilmi, I. N., Cheah, P., & Goh, K. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12175 · Cited by 17
Effect of Oleic Acid on the Levels of Eight Metal Ions in Human Hepatoma SMMC-7721 Cells
Wang, S., Kuang, X., Fang, Z., Huang, Z., & Shi, P. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0018-4 · Cited by 17
Pediatric non-alcoholic fatty liver disease: Recent advances
Corte, C. D., Vajro, P., Socha, P., & Nobili, V. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.02.008 · Cited by 17
Wani, F. A., Albahrawy, A. Z., & Rahiman, S. (2015) · Open Journal of Pathology · doi:10.4236/ojpathology.2015.53011 · Cited by 17
Passmore, E., Shepherd, B., Milat, A., Maher, L., Hennessey, K., Havrlant, R., Maxwell, M., Hodge, W., Christian, F., Richards, J. A., et al. (2017) · BMC Public Health · doi:10.1186/s12889-017-4955-7 · Cited by 17
Kim, Y., Chang, Y., Ryu, S., Cho, I. Y., Kwon, M., Sohn, W., Kim, M. K., Wild, S. H., & Byrne, C. D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac255 · Cited by 16
Rahimpour, Z., Hoseini, R., & Behpour, N. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02457-w · Cited by 17
Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes
Shannon, C. E., Chathail, M. B. N., Mullin, S. M., Meehan, A., McGillicuddy, F. C., & Roche, H. M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09821-5 · Cited by 20
Amini‐Salehi, E., Nayak, S. S., Maddineni, G., Mahapatro, A., Keivanlou, M., Moghadam, S. S., Vakilpour, A., Aleali, M. S., Joukar, F., Hashemi, M., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001740 · Cited by 17
Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice
Tahara, A., & Takasu, T. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1713802 · Cited by 16
Bhowmick, S., Singh, V., Jash, S., Lal, M., & Roy, S. S. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.007 · Cited by 16
Rahimi, G. R. M., & Hosseini, S. R. A. (2022) · Biological Research For Nursing · doi:10.1177/10998004211068026 · Cited by 17
Aubin, C. R. S., Fisher, A., Hernández, J. A. F., Broderick, T. L., & Al‐Nakkash, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s358256 · Cited by 16
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
d’Angelo, M., Castelli, V., Tupone, M. G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A., & Benedetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215422 · Cited by 17
The Role of Diet in Non-alcoholic Fatty Liver Disease
Jun, D. W. (2013) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2013.61.5.243 · Cited by 15
Choi, H., Lee, M. Y., Kim, H., Oh, B. K., Lee, S. J., Kang, J., Lee, S. H., Kim, B. J., Kim, B. S., Kang, J. H., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13128-6 · Cited by 17
DiStefano, J. K. (2023) · Nutrients · doi:10.3390/nu15122670 · Cited by 15
Huang, Y., Xu, J., Yang, Y., Wan, T., Wang, H., & Li, X. (2024) · Nutrients · doi:10.3390/nu16132063 · Cited by 15
Sakai, H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.394 · Cited by 15
Haidari, F., Hojhabrimanesh, A., Helli, B., Seyedian, S. S., Angali, K. A., & Abiri, B. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01502-w · Cited by 15
Xia, Y., Gao, Z., Yang, C., Duan, K., Ren, L., & Song, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1170881 · Cited by 16
Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
Gallacher, J., & McPherson, S. (2018) · European Medical Journal · doi:10.33590/emj/10314271 · Cited by 15
S2k-Leitlinie Klinische Ernährung in der Hepatologie
Plauth, M., Bechmann, L. P., Grajecki, D., Gundling, F., Kramer, L., Kremer, A. E., Rau, M., Schneider, A., Tacke, F., & van Thiel, I. (2024) · Aktuelle Ernährungsmedizin · doi:10.1055/a-2338-1144 · Cited by 14
Linden, M. A., Fletcher, J. A., Meers, G. M.-E., Thyfault, J. P., Laughlin, M. H., & Rector, R. S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00089.2016 · Cited by 14
Paris, T., George, E. S., Roberts, S. K., & Tierney, A. C. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000890 · Cited by 15
Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease
Glass, O., Radia, A., Kraus, W. E., & Abdelmalek, M. F. (2017) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk2040035 · Cited by 14
Zhao, X.-J. G., Chen, Y., Fu, B., Zhang, W., Liu, Z., & Zhuo, H. (2016) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7842 · Cited by 14
Mohammadi, F., Ghalavand, A., & Delaramnasab, M. (2019) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.90213 · Cited by 14
Cueto-Galán, R., Fontalba-Navas, A., Gutiérrez‐Bedmar, M., Ruiz‐Canela, M., Martínez‐González, M. Á., Alves, L., Babió, N., Fitó, M., Ros, E., Fiol, M., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1518082 · Cited by 15
Goldschmidt, I., Nanni, A., Streckenbach, C., Schnell, K., Danne, T., & Baumann, U. (2015) · BioMed Research International · doi:10.1155/2015/457473 · Cited by 13
Talavera-Urquijo, E., Rodríguez-Navarro, S., Beisani, M., Salcedo, M. T., Chakkur, A., Arús-Avilés, M., Pérez, M. C., Augustín, S., Martell, M., & Balibrea, J. M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2805-4 · Cited by 13
Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition
Lin, M., Zhao, S., Shen, L., & Xu, D. (2014) · Drug Safety · doi:10.1007/s40264-014-0147-x · Cited by 13
Hepatic gene expression in mouse models of non‐alcoholic fatty liver disease after acute exercise
Piguet, A., Guarino, M., Potaczek, D. P., Garn, H., & Dufour, J. (2019) · Hepatology Research · doi:10.1111/hepr.13323 · Cited by 13
Schübel, R., Nonnenmacher, T., Sookthai, D., Maldonado, S. G., Sowah, S. A., von Stackelberg, O., Schlett, C. L., Grafetstätter, M., Nabers, D., Johnson, T., et al. (2019) · Nutrients · doi:10.3390/nu11030544 · Cited by 13
Modifiers of Liver-Related Manifestation in the Course of NAFLD
Nasr, P., Blomdahl, J., Kechagias, S., & Ekstedt, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200310142803 · Cited by 13
Nagao, Y., Takahashi, H., Kawaguchi, A., & Kitagaki, H. (2021) · Reports — Medical Cases Images and Videos · doi:10.3390/reports4040036 · Cited by 13
Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
Bae, J., & Lee, B. (2023) · Biomolecules · doi:10.3390/biom13101506 · Cited by 12
The role of exercise in treating NAFLD
Reynoso, E., & Lavine, J. E. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.98 · Cited by 12
Samji, N. S., Verma, R., Keri, K., Singal, A. K., Ahmed, A., Rinella, M. E., Bernstein, D., Abdelmalek, M. F., & Satapathy, S. K. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05716-1 · Cited by 12
The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease
Kim, A., Krishnan, A., Hamilton, J. P., & Woreta, T. A. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.10.013 · Cited by 12
Li, ., Hua, S., Chen, G., Strizich, G., Kuniholm, M. H., Shan, Z., Talavera, G. A., Castañeda, S. F., Gellman, M. D., Cai, J., et al. (2020) · Liver International · doi:10.1111/liv.14514 · Cited by 12
Welsh, P. I., Cezard, G. I., Gill, J. M. R., Wallia, S., Douglas, A., Sheikh, A., Wild, S. H., Tuomilehto, J., McKnight, J. A., Murray, G. D., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.35 · Cited by 12
Jia, R., Hou, Y., Zhou, L., Zhang, L., Li, B., & Zhu, J. (2024) · Animals · doi:10.3390/ani14223204 · Cited by 11
Ying, Y., Ji, Y., Ju, R., Chen, J., & Chen, M. (2025) · BMC Gastroenterology · doi:10.1186/s12876-024-03579-z · Cited by 11
Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review.
Karbasi-Afshar, R., Saburi, A., & Khedmat, H. (2014) · Europe PMC (PubMed Central) · Cited by 11
Reinson, T., Byrne, C. D., Patel, J., El-Gohary, M., & Moore, M. V. (2021) · BJGP Open · doi:10.3399/bjgpo.2021.0145 · Cited by 11
Li, L., Shu, X., Yi, Y., Wang, C., Li, J., Ding, Y., Li, J., & Chang, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02082-4 · Cited by 11
Chan, W., Tan, A. T. B., Vethakkan, S. R., Tah, P., Vijayananthan, A., & Goh, K. (2015) · PubMed · doi:10.6133/apjcn.2015.24.2.15 · Cited by 11
Rodriguez-Echevarria, R., Macías-Barragán, J., Parra-Vargas, M., Dávila-Rodríguez, J., Amezcua-Galvez, E., & Armendáriz-Borunda, J. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i4.461 · Cited by 12
Xia, Y., Lu, Z., Lu, M. M., Liu, M., Liu, L., Meng, G., Yu, B., Wu, H., Bao, X., Gu, Y., et al. (2018) · Nutrition · doi:10.1016/j.nut.2018.09.033 · Cited by 11
Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
Morrison, M., Hughes, H., Naggie, S., & Syn, W. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05861-7 · Cited by 11
Radwan, M. M., Radwan, B. M., Nandipati, K. C., Hunter, W. J., & Agrawal, D. K. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.816484 · Cited by 11
Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop
Peters, H. P. F., Schrauwen, P., Verhoef, P., Byrne, C. D., Mela, D. J., Pfeiffer, A. F. H., Risérus, U., Rosendaal, F. R., & Schrauwen‐Hinderling, V. B. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.13 · Cited by 11
Franco, I., Bianco, A., Bonfiglio, C., Curci, R., Campanella, A., & Osella, A. R. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08804-9 · Cited by 10
Jawahar, A., González, B., Balasubramanian, N., Adams, W. M., & Goldberg, A. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001502 · Cited by 10
Fatty liver index relationship with biomarkers and lifestyle: result from RaNCD cohort study
Kamari, N., Fateh, H. L., Darbandi, M., Najafi, F., Moradi, M., & Pasdar, Y. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02785-5 · Cited by 10
Seifi, N., Bahari, H., Soltani, S., Nikoumanesh, M., Hajipoor, M., Ferns, G. A., & Ghayour‐Mobarhan, M. (2023) · Digital Health · doi:10.1177/20552076231187597 · Cited by 10
Eating a healthy lunch improves serum alanine aminotransferase activity
Iwamoto, M., Yagi, K., Yazumi, K., Komine, A., Shirouchi, B., & Sato, M. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-134 · Cited by 10
Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease?
Roman, J. H., & Patel, S. S. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.10.001 · Cited by 10
Guagnano, M. T., D’Ardes, D., Rossi, I., Santilli, F., Schiavone, C., Bucci, M., & Cipollone, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102759 · Cited by 10
Review on Liver Steatosis and its Impact on Liver Transplantation
Ahmed, E. A. (2017) · Journal of Liver Research Disorders & Therapy · doi:10.15406/jlrdt.2017.03.00064 · Cited by 10
Pei, Y., He, Y., Wang, X., Xie, C., Li, L., Sun, Q., Liu, L., Shan, S., Wang, P., Liu, T., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176668 · Cited by 9
Nie, L., He, K., Wu, W., Zhang, H., Gao, C., Xiong, B., Li, S., Xie, Y., Xie, H., & Yang, X. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16542 · Cited by 9
Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery
Abu-Rumaileh, M. A., Haddad, R. A., Yosef, M., Esfandiari, N. H., Kraftson, A. T., Khairi, S., Lager, C. J., Bushman, J., Khalatbari, S., Tincopa, M. A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06865-z · Cited by 9
The Genetics of Nonalcoholic Fatty Liver Disease: Role of Diet as a Modifying Factor
Kalafati, I. P., Borsa, D., & Dedoussis, G. V. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0085-3 · Cited by 9
NAFLD and cardiovascular disease
Martins, E., & Oliveira, A. B. F. D. (2018) · Porto Biomedical Journal · doi:10.1016/j.pbj.0000000000000002 · Cited by 9
Abdel-Mobdy, A. E., Khattab, M. S., Mahmoud, E. A., Mohamed, E. R., & Abdel‐Rahim, E. A. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-020-00842-3 · Cited by 9
FGF-21 LEVELS AND LIVER INFLAMMATORY BIOMARKERS IN OBESE SUBJECTS AFTER WEIGHT LOSS.
Cantero, I., Abete, I., Bullón‐Vela, V., Crujeiras, A. B., Ff, C., Zulet, M. Á., & Martínez, J. A. (2021) · Archives of Medical Science · doi:10.5114/aoms/98948 · Cited by 9
Tedesco, C. C., Bonfiglio, C., Notarnicola, M., Rendina, M. G., Castellaneta, A., Leo, A. D., Giannelli, G., & Fontana, L. (2023) · Nutrients · doi:10.3390/nu15214673 · Cited by 9
Pennisi, G., Maria, G. D., Enea, M., Vaccaro, M., Celsa, C., Antonucci, M., Ciancimino, G., Ciccioli, C., Infantino, G., Mantia, C. L., et al. (2025) · Liver International · doi:10.1111/liv.70056 · Cited by 9
Brea, Á., Pintó, X., Ascaso, J. F., Blasco, M., Rodríguez, Á. D., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Millán, J., & Pedro‐Botet, J. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.06.002 · Cited by 8
Association between physical activity and diet quality of obese and non-obese MAFLD
Wang, S., Xia, B. X., Luo, T., & Wang, P. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.07.022 · Cited by 8
Arslan, I., Ulas, T., Karakas, E. Y., Demir, M., Eren, M. A., Torun, A., & Sabuncu, T. (2017) · Periodicum Biologorum · doi:10.18054/pb.v119i1.4180 · Cited by 8
Coker, M. S., Ladd, K., Murphy, C. J., Ruby, B. C., Shriver, T. C., Schoeller, D. A., Newcomer, B. R., Bateman, T., Bartlett, L., & Coker, R. H. (2020) · Physiological Reports · doi:10.14814/phy2.14682 · Cited by 6
Taha, M. M., Aneis, Y. M., Mohamady, H. M., Alrasheedy, S. A., & ELSAYED, S. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250337 · Cited by 8
Non-Alcoholic Fatty Liver Disease in Patients with Diabetes Mellitus: A Clinician’s Perspective
Kashanian, S. M., & Fuchs, M. A. (2015) · International Journal of Digestive Diseases · doi:10.4172/2472-1891.100010 · Cited by 8
Sehatpour, F., Salehi, A., Vardanjani, H. M., Poustchi, H., Gandomkar, A., & Malekzadeh, R. (2019) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2020.159 · Cited by 8
Han, B., Jian, Y., Xia, X., Hu, W., Zhang, L., & Zhou, P. (2020) · Food & Function · doi:10.1039/d0fo00741b · Cited by 8
Short-term combined training reduces hepatic steatosis and improves hepatic insulin signaling
Pereira, R. M., Rodrigues, K. C. D. C., Sant’Ana, M. R., Peruca, G. F., Anaruma, C. P., de Campos, T. D. P., Canciglieri, R. D. S., de Melo, D. G., Simabuco, F. M., da Silva, A. S. R., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120124 · Cited by 8
Fonseca, J., Nunes, G. F. D., Fonseca, C., Canhoto, M., Barata, A. T., & Santos, C. A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.036 · Cited by 8
TINIAKOS, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00005-3 · Cited by 7
Dawei, G. U. O., Sun, J., & Feng, S. (2024) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.24.16206-8 · Cited by 10
Kazeminasab, F., Mohebinejad, M., Mahboobi, M. H., Nojoumi, M., Belyani, S., Bagheri, R., & Dutheil, F. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2528534 · Cited by 11
Cirrosis hepática o falla hepática crónica agudizada: definición y clasificación
Miño–Bernal, J. F., Morales, E. L., Sandino, N. J., & Molano-Franco, D. (2022) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1052 · Cited by 7
Liu, Z., Huang, H., Xie, J., Shen, Q., & Xu, C. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.06.025 · Cited by 8
Voudouris, D., Horianopoulou, M., Apostolopoulou, Z., Chryssanthopοulos, C., Bardopoulou, M., Maridaki, M. D., Vassilakopoulos, T., Koutsilieris, M., & Philippou, Α. (2023) · Metabolites · doi:10.3390/metabo13101074 · Cited by 8
Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Nendouvhada, L. P., Sibuyi, N. R. S., Fadaka, A. O., Meyer, S., Madiehe, A. M., Meyer, M., & Gabuza, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115571 · Cited by 8
Esteatosis hepática: diagnóstico y seguimiento
Caballería, L., Majeed, I., Martínez-Escudé, A., Pillasagua, I. A., & Torán‐Monserrat, P. (2017) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2017.03.001 · Cited by 7
Koeckerling, D., Tomlinson, J., & Cobbold, J. (2020) · Endocrine Connections · doi:10.1530/ec-20-0174 · Cited by 7
Fatahi, S., Sohouli, M. H., Rayi, A., Teymoori, F., & Shidfar, F. (2021) · PubMed Central · Cited by 7
Identifying and Treating Nonalcoholic Fatty Liver Disease.
Hunt, C. M., Turner, M. J., Gifford, E. J., Britt, R. B., & Su, G. L. (2019) · Europe PMC (PubMed Central) · Cited by 7
Current Treatment Options, Including Diet, Exercise, and Medications
Noureddin, M., & Abdelmalek, M. F. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.008 · Cited by 6
Wentworth, B. J. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.45 · Cited by 6
Brea, Á., Pintó, X., Ascaso, J. F., Blasco, M., Díaz, Á., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Millán, J., & Pedro‐Botet, J. (2017) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2017.07.001 · Cited by 6
Pirogova, I. Y., Yakovleva, S. V., Neuymina, T. V., Sinitsyn, S. P., Чулков, В. С., & Николаевна, Ш. Т. (2018) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2018-28-4-66-75 · Cited by 6
Nutritional and Dietary Interventions for Nonalcoholic Fatty Liver Disease
Cai, C. X., Carlos, S., Solaimani, P., Trivedi, B. J., Tran, C. T., & Castelino‐Prabhu, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00029-x · Cited by 6
Nonalcoholic Fatty Liver Disease
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_9 · Cited by 6
A healthy liver will always deliver: development of a NAFLD awareness comic
Pagès, M. A. I., Tavares, R., Azul, A. M., & Ramalho‐Santos, J. (2022) · Health Promotion International · doi:10.1093/heapro/daac165 · Cited by 9
The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease
MacLean, C., Dillon, J. F., Babraj, J., & Vollaard, N. B. J. (2017) · The Physician and Sportsmedicine · doi:10.1080/00913847.2018.1411171 · Cited by 8
Metadata
- Authors
- Thoma, C., Day, C. P., & Trenell, M. I.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Trenell, Michael I.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 56
- Issue
- 1
- Pages
- 255-266
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2010662354
- Cited by
- 523
- References
- 53
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 30 · 2023: 37 · 2022: 35 · 2021: 43 · 2020: 42 · 2019: 36 · 2018: 32 · 2017: 46 · 2016: 46 · 2015: 46 · 2014: 40 · 2013: 32 · 2012: 23
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (SRF-2011-04-017)
- Medical Research Council (MC_G0802536)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- non-alcoholic fatty liver disease, lifestyle intervention, dietary intervention, physical activity, weight loss, liver fat, hepatic steatosis, liver fibrosis, liver inflammation, insulin sensitivity, glycemic control, transaminases
- MeSH terms
- Adult, Aged, Clinical Trials as Topic, Combined Modality Therapy, Diet Therapy, Exercise Therapy, Fatty Liver, Female, Humans, Life Style, Male, Middle Aged, Motor Activity, Prospective Studies, Lipid Metabolism, Weight Reduction Programs, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
